The effect of diet on hypertensive pathology: is there a link via gut microbiota-driven immune-metabolism?

Hamdi Ahmed Jama, Anna Beale, Waled Shihata, Francine Z. Marques

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Over the past decade, the immune system has emerged as an important component in the aetiology of hypertension. There has been a blooming interest in the contribution of the gut microbiota, the microbes that inhabit our small and large intestine, to blood pressure (BP) regulation. The gastrointestinal tract houses the largest number of immune cells in our body, thus, it is no surprise that its microbiota plays an important functional role in the appropriate development of the immune system through a co-ordinated sequence of events leading to immune tolerance of commensal bacteria. Importantly, recent evidence supports that the gut microbiota can protect or promote the development of experimental hypertension and is likely to have a role in human hypertension. One of the major modulators of the gut microbiota is diet: diets that emphasize high intake of fermentable fibre, such as the Mediterranean diet and the Dietary Approaches to Stop Hypertension, promote expansion of protective microbes that release gut metabolites such as short-chain fatty acids, which are immune-, BP-, and cardio-protective, likely acting through G-coupled protein receptors. In contrast, diets lacking fibre or high in salt and fat, such as the Western diet, reduce prevalence of commensal microbial species and support a pathogenic and pro-inflammatory environment, including the release of the pro-atherosclerotic trimethylamine N-oxide. Here, we review the current understanding of the gut microbiota-driven immune dysfunction in both experimental and clinical hypertension, and how these changes may be addressed through dietary interventions.
Original languageEnglish
Pages (from-to)1435-1447
Number of pages13
JournalCardiovascular Research
Volume115
Issue number9
DOIs
Publication statusPublished - 2019

Keywords

  • Hypertensive
  • GPR109A
  • GPR43
  • GPR41
  • GPCRs
  • Tregs
  • Th17
  • Essential hypertension
  • Metabolites
  • Metabolism
  • Immune dysfunction
  • Gut microbiota

Cite this

@article{000463da6df54e9f911f1c40f9c1a3b3,
title = "The effect of diet on hypertensive pathology: is there a link via gut microbiota-driven immune-metabolism?",
abstract = "Over the past decade, the immune system has emerged as an important component in the aetiology of hypertension. There has been a blooming interest in the contribution of the gut microbiota, the microbes that inhabit our small and large intestine, to blood pressure (BP) regulation. The gastrointestinal tract houses the largest number of immune cells in our body, thus, it is no surprise that its microbiota plays an important functional role in the appropriate development of the immune system through a co-ordinated sequence of events leading to immune tolerance of commensal bacteria. Importantly, recent evidence supports that the gut microbiota can protect or promote the development of experimental hypertension and is likely to have a role in human hypertension. One of the major modulators of the gut microbiota is diet: diets that emphasize high intake of fermentable fibre, such as the Mediterranean diet and the Dietary Approaches to Stop Hypertension, promote expansion of protective microbes that release gut metabolites such as short-chain fatty acids, which are immune-, BP-, and cardio-protective, likely acting through G-coupled protein receptors. In contrast, diets lacking fibre or high in salt and fat, such as the Western diet, reduce prevalence of commensal microbial species and support a pathogenic and pro-inflammatory environment, including the release of the pro-atherosclerotic trimethylamine N-oxide. Here, we review the current understanding of the gut microbiota-driven immune dysfunction in both experimental and clinical hypertension, and how these changes may be addressed through dietary interventions.",
keywords = "Hypertensive, GPR109A, GPR43, GPR41, GPCRs, Tregs, Th17, Essential hypertension, Metabolites, Metabolism, Immune dysfunction, Gut microbiota",
author = "Jama, {Hamdi Ahmed} and Anna Beale and Waled Shihata and Marques, {Francine Z.}",
year = "2019",
doi = "10.1093/cvr/cvz091",
language = "English",
volume = "115",
pages = "1435--1447",
journal = "Cardiovascular Research",
issn = "0008-6363",
publisher = "Oxford University Press",
number = "9",

}

The effect of diet on hypertensive pathology: is there a link via gut microbiota-driven immune-metabolism? / Jama, Hamdi Ahmed; Beale, Anna; Shihata, Waled; Marques, Francine Z.

In: Cardiovascular Research, Vol. 115, No. 9, 2019, p. 1435-1447.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - The effect of diet on hypertensive pathology: is there a link via gut microbiota-driven immune-metabolism?

AU - Jama, Hamdi Ahmed

AU - Beale, Anna

AU - Shihata, Waled

AU - Marques, Francine Z.

PY - 2019

Y1 - 2019

N2 - Over the past decade, the immune system has emerged as an important component in the aetiology of hypertension. There has been a blooming interest in the contribution of the gut microbiota, the microbes that inhabit our small and large intestine, to blood pressure (BP) regulation. The gastrointestinal tract houses the largest number of immune cells in our body, thus, it is no surprise that its microbiota plays an important functional role in the appropriate development of the immune system through a co-ordinated sequence of events leading to immune tolerance of commensal bacteria. Importantly, recent evidence supports that the gut microbiota can protect or promote the development of experimental hypertension and is likely to have a role in human hypertension. One of the major modulators of the gut microbiota is diet: diets that emphasize high intake of fermentable fibre, such as the Mediterranean diet and the Dietary Approaches to Stop Hypertension, promote expansion of protective microbes that release gut metabolites such as short-chain fatty acids, which are immune-, BP-, and cardio-protective, likely acting through G-coupled protein receptors. In contrast, diets lacking fibre or high in salt and fat, such as the Western diet, reduce prevalence of commensal microbial species and support a pathogenic and pro-inflammatory environment, including the release of the pro-atherosclerotic trimethylamine N-oxide. Here, we review the current understanding of the gut microbiota-driven immune dysfunction in both experimental and clinical hypertension, and how these changes may be addressed through dietary interventions.

AB - Over the past decade, the immune system has emerged as an important component in the aetiology of hypertension. There has been a blooming interest in the contribution of the gut microbiota, the microbes that inhabit our small and large intestine, to blood pressure (BP) regulation. The gastrointestinal tract houses the largest number of immune cells in our body, thus, it is no surprise that its microbiota plays an important functional role in the appropriate development of the immune system through a co-ordinated sequence of events leading to immune tolerance of commensal bacteria. Importantly, recent evidence supports that the gut microbiota can protect or promote the development of experimental hypertension and is likely to have a role in human hypertension. One of the major modulators of the gut microbiota is diet: diets that emphasize high intake of fermentable fibre, such as the Mediterranean diet and the Dietary Approaches to Stop Hypertension, promote expansion of protective microbes that release gut metabolites such as short-chain fatty acids, which are immune-, BP-, and cardio-protective, likely acting through G-coupled protein receptors. In contrast, diets lacking fibre or high in salt and fat, such as the Western diet, reduce prevalence of commensal microbial species and support a pathogenic and pro-inflammatory environment, including the release of the pro-atherosclerotic trimethylamine N-oxide. Here, we review the current understanding of the gut microbiota-driven immune dysfunction in both experimental and clinical hypertension, and how these changes may be addressed through dietary interventions.

KW - Hypertensive

KW - GPR109A

KW - GPR43

KW - GPR41

KW - GPCRs

KW - Tregs

KW - Th17

KW - Essential hypertension

KW - Metabolites

KW - Metabolism

KW - Immune dysfunction

KW - Gut microbiota

U2 - 10.1093/cvr/cvz091

DO - 10.1093/cvr/cvz091

M3 - Article

VL - 115

SP - 1435

EP - 1447

JO - Cardiovascular Research

JF - Cardiovascular Research

SN - 0008-6363

IS - 9

ER -